hypoxanthine has been researched along with Developmental Disabilities in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blennow, M; Forssberg, H; Hagberg, H; Hesser, U; Jonsson, S; Katz-Salamon, M; Lagercrantz, H; Rosengren, L | 1 |
| Brown, JK; Harkness, RA; Laing, I | 1 |
1 trial(s) available for hypoxanthine and Developmental Disabilities
| Article | Year |
|---|---|
Clinical and biochemical assessments of damage due to perinatal asphyxia: a double blind trial of a quantitative method.
Topics: Asphyxia Neonatorum; Child Development; Clinical Trials as Topic; Creatinine; Developmental Disabilities; Double-Blind Method; Growth Disorders; Humans; Hypoxanthine; Hypoxanthines; Hypoxia, Brain; Infant; Infant, Newborn; Kidney Diseases; Methods; Xanthine; Xanthines | 1988 |
1 other study(ies) available for hypoxanthine and Developmental Disabilities
| Article | Year |
|---|---|
Glial fibrillary acidic protein is increased in the cerebrospinal fluid of preterm infants with abnormal neurological findings.
Topics: Biomarkers; Brain Damage, Chronic; Case-Control Studies; Developmental Disabilities; Female; Gestational Age; Glial Fibrillary Acidic Protein; Glutamic Acid; Humans; Hypoxanthine; Hypoxanthines; Infant, Newborn; Infant, Premature, Diseases; Male; Norepinephrine; Predictive Value of Tests | 1996 |